Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure allows for selective modification, making it valuable in optimizing drug potency and metabolic stability during medicinal chemistry research. Commonly employed in late-stage functionalization to introduce the pyrazolopyridine scaffold, which is known for favorable binding to biological targets and improved pharmacokinetic profiles.